Janet Hoogstraate

Janet Hoogstraate

Director/Board Member at ALZECURE PHARMA AB

Net worth: 40 354 $ as of 30/09/2026

59 year
Health Technology
Consumer Services

Profile

Dr. Janet Hoogstraate is a Chief Executive Officer at NorthX Biologics Matfors AB, an Independent Director at AlzeCure Pharma AB, a Chairman at Stockholm Brain Institute, a Chief Executive Director & Director at Hoogstraate Consulting AB. and a Member-Management Board at Enable2.
She is on the Board of Directors at AlzeCure Pharma AB, Hoogstraate Consulting AB., Apotek Produktion & Laboratorier AB, The Dutch Chamber of Commerce In Sweden and Mireca Medicines GmbH.
Dr. Hoogstraate was previously employed as a Chief Executive Officer by Valneva Sweden AB. She received her MBA from Hult International Business School and a doctorate degree from the University of Leiden.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2025 53,978 ( 0.04% ) 40 354 $ 30/09/2026

Janet Hoogstraate active positions

CompaniesPositionStart
ALZECURE PHARMA AB Director/Board Member 01/01/2023
Director/Board Member 01/05/2017
Hoogstraate Consulting AB.
Chief Executive Officer -
The Dutch Chamber of Commerce In Sweden
Director/Board Member -
Chief Executive Officer 23/08/2023
Stockholm Brain Institute
Chairman -
Director/Board Member -

Former positions of Janet Hoogstraate

CompaniesPositionEnd
Chief Executive Officer -
See the detail of Janet Hoogstraate's experience

Education of Janet Hoogstraate

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

39

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Health Technology

Consumer Services

Stockholm Brain Institute

Health Technology

Health Technology

Health Technology

Health Technology

Hoogstraate Consulting AB.

The Dutch Chamber of Commerce In Sweden

  1. Stock Market
  2. Insiders
  3. Janet Hoogstraate